Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kelly Maloney

Concepts (374)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
2025
294
5.580
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
11
2025
89
1.630
Why?
Antineoplastic Combined Chemotherapy Protocols
18
2026
1962
1.230
Why?
Down Syndrome
6
2023
534
1.210
Why?
Burkitt Lymphoma
3
2024
62
0.930
Why?
Leukemia, Myeloid, Acute
7
2026
684
0.870
Why?
Asparaginase
8
2020
30
0.830
Why?
Fishes
1
2024
108
0.800
Why?
Agriculture
1
2024
104
0.780
Why?
Child
74
2026
22712
0.730
Why?
Bayes Theorem
1
2024
433
0.720
Why?
Consolidation Chemotherapy
2
2019
10
0.650
Why?
Neoplasm Recurrence, Local
6
2025
1148
0.610
Why?
Child, Preschool
49
2026
11863
0.600
Why?
Ecosystem
1
2024
590
0.580
Why?
Disease-Free Survival
12
2024
771
0.540
Why?
Leukemia
4
2021
245
0.540
Why?
Oncogene Proteins, Fusion
6
2024
211
0.530
Why?
Mercaptopurine
5
2017
15
0.510
Why?
Prognosis
17
2026
4310
0.500
Why?
Antineoplastic Agents
7
2019
2202
0.450
Why?
Infant
36
2026
10101
0.450
Why?
Recurrence
12
2025
1138
0.450
Why?
Preleukemia
1
2015
2
0.450
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
127
0.440
Why?
Molecular Targeted Therapy
3
2021
434
0.430
Why?
Drug Hypersensitivity
3
2017
90
0.430
Why?
Leukemia, Monocytic, Acute
1
2014
3
0.420
Why?
Sarcoma, Myeloid
1
2014
4
0.420
Why?
Neoplasm, Residual
7
2023
139
0.400
Why?
Adolescent
42
2026
22507
0.390
Why?
Bone Marrow Transplantation
1
2014
294
0.380
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
26
0.360
Why?
Erwinia
2
2020
3
0.360
Why?
Medical Oncology
5
2025
332
0.350
Why?
Tumor Suppressor Proteins
3
1999
324
0.350
Why?
Humans
86
2026
145305
0.350
Why?
Chromosome Aberrations
2
2022
163
0.340
Why?
Acute Kidney Injury
1
2019
870
0.340
Why?
Neutropenia
2
2022
155
0.330
Why?
Male
58
2026
72628
0.330
Why?
Hematopoietic Stem Cell Transplantation
2
2019
677
0.330
Why?
Stem Cell Transplantation
3
2019
191
0.320
Why?
Rhabdomyosarcoma
1
2011
64
0.320
Why?
Cell Cycle Proteins
3
1999
630
0.310
Why?
Carrier Proteins
3
1999
739
0.310
Why?
Sarcoma, Ewing
1
2011
103
0.310
Why?
Biomarkers, Tumor
3
2026
1325
0.300
Why?
Ploidies
2
2019
20
0.300
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
192
0.290
Why?
Core Binding Factor Alpha 2 Subunit
3
2021
30
0.280
Why?
Genes, Tumor Suppressor
2
1999
83
0.280
Why?
Catheter-Related Infections
2
2022
95
0.280
Why?
Survival Rate
8
2024
2100
0.280
Why?
Cyclophosphamide
4
2019
267
0.280
Why?
Female
56
2026
78605
0.270
Why?
Catheterization, Central Venous
2
2022
123
0.260
Why?
Philadelphia Chromosome
2
2018
18
0.260
Why?
Medication Adherence
3
2017
541
0.250
Why?
Gene Deletion
2
1998
389
0.240
Why?
Vincristine
4
2021
141
0.230
Why?
Neoplasm Proteins
2
2018
444
0.230
Why?
Trisomy
2
2021
78
0.230
Why?
Antimetabolites, Antineoplastic
2
2017
105
0.230
Why?
Etoposide
2
2019
167
0.230
Why?
Ikaros Transcription Factor
1
2025
23
0.220
Why?
Young Adult
15
2024
14163
0.210
Why?
Maryland
1
2024
66
0.210
Why?
Invertebrates
1
2024
24
0.210
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
73
0.210
Why?
Rivers
1
2024
67
0.200
Why?
Treatment Outcome
12
2023
11731
0.200
Why?
PAX5 Transcription Factor
2
2024
14
0.200
Why?
Anxiety
3
2016
1113
0.200
Why?
Polymorphism, Single Nucleotide
4
2025
2152
0.190
Why?
Genomics
4
2025
842
0.190
Why?
Gene Rearrangement
3
2019
155
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
76
0.180
Why?
Polyethylene Glycols
5
2020
655
0.180
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
4
0.180
Why?
Induction Chemotherapy
2
2019
87
0.180
Why?
Central Venous Catheters
1
2022
53
0.170
Why?
Health Equity
1
2024
129
0.170
Why?
Environmental Monitoring
1
2024
379
0.170
Why?
Program Evaluation
2
2017
949
0.170
Why?
Prednisone
2
2019
222
0.170
Why?
Lymphoma
1
2023
233
0.170
Why?
Doxorubicin
2
2022
398
0.160
Why?
Lung Neoplasms
1
2014
2652
0.160
Why?
Adult
23
2023
40627
0.160
Why?
Translocation, Genetic
2
2013
118
0.160
Why?
Maintenance Chemotherapy
2
2017
42
0.160
Why?
Bacterial Infections
1
2022
246
0.150
Why?
Immunocompromised Host
1
2021
201
0.150
Why?
Diploidy
1
2019
16
0.150
Why?
Genes, p16
1
1999
13
0.150
Why?
Risk Factors
11
2022
10816
0.150
Why?
Hyperglycemia
1
2023
376
0.140
Why?
Chromosomes, Human, Pair 19
1
1998
26
0.140
Why?
Chromosomes, Human, Pair 17
1
1998
55
0.140
Why?
Quality of Life
3
2024
3197
0.140
Why?
Myelodysplastic Syndromes
1
2020
147
0.140
Why?
Antibodies, Bispecific
1
2019
69
0.140
Why?
Rituximab
1
2019
211
0.140
Why?
Chromosomes, Human, Pair 1
1
1998
79
0.140
Why?
Prospective Studies
9
2022
8011
0.140
Why?
Mutagenesis
1
1999
192
0.140
Why?
Prostate-Specific Antigen
2
2009
162
0.130
Why?
Substance Withdrawal Syndrome
1
2020
188
0.130
Why?
Patient Safety
1
2021
349
0.130
Why?
Proto-Oncogenes
1
1997
29
0.130
Why?
Family Relations
2
2016
88
0.130
Why?
Thioguanine
1
2017
18
0.130
Why?
Thionucleotides
1
2017
35
0.130
Why?
Apyrase
1
2017
26
0.130
Why?
Oncologists
1
2017
46
0.130
Why?
Blast Crisis
1
2016
35
0.120
Why?
Carboxypeptidases A
1
2016
2
0.120
Why?
Follow-Up Studies
6
2021
5431
0.120
Why?
Pediatricians
1
2017
121
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
269
0.120
Why?
Adrenal Cortex Hormones
1
2019
480
0.120
Why?
Sepsis
1
2022
641
0.120
Why?
Osteonecrosis
1
2015
23
0.110
Why?
Nausea
1
2016
111
0.110
Why?
Retrospective Studies
10
2023
17149
0.110
Why?
Mentors
2
2017
219
0.110
Why?
Cohort Studies
6
2026
5982
0.110
Why?
Depression
2
2016
1561
0.110
Why?
Pancreatitis
1
2016
145
0.110
Why?
Central Nervous System Neoplasms
1
2017
175
0.110
Why?
Dexamethasone
4
2021
372
0.110
Why?
Monitoring, Physiologic
1
2017
289
0.110
Why?
Fusion Proteins, bcr-abl
2
2016
69
0.110
Why?
Longitudinal Studies
7
2016
2959
0.110
Why?
Mutation
4
2022
4104
0.110
Why?
Mentoring
1
2017
166
0.110
Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
14
0.110
Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
72
0.110
Why?
High-Throughput Nucleotide Sequencing
1
2017
550
0.100
Why?
Bacteremia
1
2016
223
0.100
Why?
Flow Cytometry
1
2018
1173
0.100
Why?
Repressor Proteins
1
1997
437
0.100
Why?
Antigens, CD
1
2017
555
0.100
Why?
Cross Infection
1
2016
263
0.100
Why?
Life Change Events
1
2014
147
0.100
Why?
Chromosomes, Human, Pair 21
1
2013
42
0.100
Why?
Pediatrics
3
2021
1118
0.100
Why?
Histone-Lysine N-Methyltransferase
2
2010
141
0.100
Why?
DNA-Binding Proteins
2
1998
1503
0.100
Why?
Immunotherapy
1
2018
660
0.100
Why?
Risk Assessment
5
2026
3686
0.100
Why?
Venous Thromboembolism
1
2017
324
0.090
Why?
Leukemia, Megakaryoblastic, Acute
1
2012
10
0.090
Why?
Myeloproliferative Disorders
1
2012
19
0.090
Why?
Transcription Factors
2
1998
1746
0.090
Why?
Karyotyping
3
2019
106
0.090
Why?
Quality Improvement
1
2021
1296
0.090
Why?
Self Report
1
2017
873
0.090
Why?
Contraindications
1
2012
91
0.090
Why?
Arabinonucleosides
1
2011
8
0.090
Why?
Adenine Nucleotides
1
2011
21
0.090
Why?
Prostatic Neoplasms
2
2009
979
0.080
Why?
Antibodies, Monoclonal
1
2018
1525
0.080
Why?
Chromosomes, Human, Pair 4
1
2010
25
0.080
Why?
Chromosomes, Human, Pair 10
1
2010
19
0.080
Why?
Pain
1
2016
784
0.080
Why?
Multivariate Analysis
4
2015
1540
0.080
Why?
T-Lymphocytes
1
2018
1984
0.080
Why?
Parents
2
2016
1404
0.070
Why?
Prostatectomy
1
2009
94
0.070
Why?
Age Factors
8
2019
3339
0.070
Why?
Bloom Syndrome
1
1988
3
0.070
Why?
Neoplasm Metastasis
1
2011
697
0.070
Why?
Juxtaglomerular Apparatus
1
2007
2
0.070
Why?
Gene Expression Regulation, Leukemic
2
2016
56
0.070
Why?
Polymerase Chain Reaction
1
2010
1054
0.060
Why?
Drug Administration Schedule
2
2017
783
0.060
Why?
Blood Coagulation
1
2008
271
0.060
Why?
Clinical Trials, Phase III as Topic
1
2026
117
0.060
Why?
Stress, Psychological
1
2014
1153
0.060
Why?
Clinical Trials as Topic
2
2024
1063
0.060
Why?
Surveys and Questionnaires
4
2024
6079
0.060
Why?
Animals
3
2024
38177
0.060
Why?
Methotrexate
2
2017
241
0.060
Why?
Remission Induction
2
2019
308
0.050
Why?
Case-Control Studies
3
2024
3613
0.050
Why?
Acute Disease
2
2019
1031
0.050
Why?
Selection Bias
1
2024
38
0.050
Why?
Personal Satisfaction
2
2017
222
0.050
Why?
Incidence
3
2019
2892
0.050
Why?
Administration, Oral
2
2017
848
0.050
Why?
Genetic Variation
1
1988
986
0.050
Why?
Kidney Neoplasms
1
2007
413
0.050
Why?
Drug Monitoring
2
2017
396
0.050
Why?
Risk
5
2023
912
0.050
Why?
Disease Progression
2
2021
2855
0.040
Why?
Proto-Oncogene Proteins c-cbl
1
2022
13
0.040
Why?
Randomized Controlled Trials as Topic
2
2020
1747
0.040
Why?
Exome
1
2022
227
0.040
Why?
Drug Therapy
1
2021
80
0.040
Why?
Menorrhagia
1
2001
22
0.040
Why?
Transcriptome
2
2019
1046
0.040
Why?
Diarrhea
2
1999
194
0.040
Why?
Bone Marrow
1
2022
306
0.040
Why?
Endocrine Glands
1
1979
14
0.040
Why?
Blood Cell Count
1
1999
54
0.040
Why?
Chromosomes, Human
1
2019
41
0.040
Why?
Cytogenetic Analysis
1
2019
33
0.040
Why?
Azacitidine
1
2020
157
0.040
Why?
Loss of Heterozygosity
1
1999
52
0.040
Why?
Viral Load
1
2021
527
0.040
Why?
Genome-Wide Association Study
2
2016
1414
0.040
Why?
Mosaicism
1
2019
73
0.040
Why?
Sequence Deletion
1
1999
193
0.040
Why?
Hypertension
1
2007
1266
0.030
Why?
Disinfectants
1
1999
47
0.030
Why?
National Cancer Institute (U.S.)
1
2018
52
0.030
Why?
Chromosomes
1
2019
108
0.030
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
280
0.030
Why?
Escherichia coli O157
1
1998
35
0.030
Why?
Infant, Newborn
4
2019
6456
0.030
Why?
Methylation
1
1998
242
0.030
Why?
Overweight
1
2023
610
0.030
Why?
Biopsy
1
2021
1079
0.030
Why?
Community Participation
1
1999
132
0.030
Why?
Genetic Predisposition to Disease
2
2017
2371
0.030
Why?
Interviews as Topic
1
2021
907
0.030
Why?
Erythrocyte Count
1
2017
21
0.030
Why?
United States
4
2021
16051
0.030
Why?
Glucose
1
2023
1049
0.030
Why?
Public Health Surveillance
1
2017
83
0.030
Why?
Escherichia coli Infections
1
1998
129
0.030
Why?
Food-Drug Interactions
1
2017
11
0.030
Why?
Injections, Intramuscular
1
2017
141
0.030
Why?
Proto-Oncogene Proteins c-ets
1
1997
56
0.030
Why?
Career Mobility
1
2017
72
0.030
Why?
Leucovorin
1
2017
101
0.030
Why?
Dairy Products
1
2017
31
0.030
Why?
Cerebrospinal Fluid
1
2017
88
0.030
Why?
MEF2 Transcription Factors
1
2016
51
0.030
Why?
Cranial Irradiation
1
2017
85
0.030
Why?
Family
1
2021
682
0.030
Why?
Water Purification
1
1999
158
0.030
Why?
Infusions, Intravenous
1
2017
423
0.030
Why?
Leukocyte Count
1
2017
316
0.030
Why?
Luciferases
1
2016
152
0.030
Why?
Methyltransferases
1
2017
74
0.030
Why?
NIH 3T3 Cells
1
2016
148
0.030
Why?
Feasibility Studies
1
2021
1103
0.030
Why?
Sulfonamides
1
2020
581
0.030
Why?
Ethers
1
1996
19
0.030
Why?
Methyl Ethers
1
1996
19
0.030
Why?
Bone Morphogenetic Protein 7
1
2015
12
0.030
Why?
Fluorides
1
1996
49
0.030
Why?
Hemorrhage
1
2001
810
0.030
Why?
Cytarabine
1
2016
66
0.030
Why?
Genotype
3
2017
1845
0.030
Why?
Health Education
1
1999
358
0.030
Why?
Anesthetics, Inhalation
1
1996
52
0.030
Why?
Severity of Illness Index
2
2017
2926
0.030
Why?
Breast Neoplasms
5
1979
2464
0.030
Why?
Histone Deacetylase Inhibitors
1
2016
220
0.030
Why?
Disease Management
1
2019
647
0.030
Why?
Spinal Dysraphism
1
1996
114
0.030
Why?
Middle Aged
10
2019
36021
0.030
Why?
Alternative Splicing
1
2017
249
0.030
Why?
Homeodomain Proteins
1
1998
530
0.030
Why?
HEK293 Cells
1
2017
744
0.030
Why?
Promoter Regions, Genetic
1
1999
1260
0.030
Why?
Sequence Analysis, RNA
1
2016
442
0.030
Why?
Intensive Care Units, Pediatric
1
2016
287
0.030
Why?
DNA Methylation
1
1999
686
0.030
Why?
Qualitative Research
1
2021
1681
0.020
Why?
Behavior
1
2014
91
0.020
Why?
Psychomotor Agitation
1
2014
70
0.020
Why?
Demography
1
2014
288
0.020
Why?
Income
1
2014
202
0.020
Why?
Algorithms
1
2021
1846
0.020
Why?
Marriage
1
2014
122
0.020
Why?
Base Sequence
1
2016
2191
0.020
Why?
Aged
9
2019
26001
0.020
Why?
Odds Ratio
1
2015
1077
0.020
Why?
Blood Glucose
1
2023
2333
0.020
Why?
In Situ Hybridization, Fluorescence
1
2013
323
0.020
Why?
Aggression
1
2014
179
0.020
Why?
Prevalence
2
2016
2838
0.020
Why?
Nucleoside Transport Proteins
1
2011
8
0.020
Why?
Kidney
2
1996
1499
0.020
Why?
Regression Analysis
1
2014
1003
0.020
Why?
Antineoplastic Agents, Alkylating
1
2011
72
0.020
Why?
Time Factors
2
2015
7186
0.020
Why?
Erythrocytes
1
2017
757
0.020
Why?
Escherichia coli
1
2015
855
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2011
177
0.020
Why?
Mice
2
2019
18394
0.020
Why?
Survival Analysis
1
2013
1386
0.020
Why?
Logistic Models
1
2015
2119
0.020
Why?
Bacteria
1
2016
891
0.020
Why?
Obesity
1
2023
3085
0.020
Why?
Kaplan-Meier Estimate
1
2011
967
0.020
Why?
Sister Chromatid Exchange
1
1988
4
0.020
Why?
Genetic Complementation Test
1
1988
66
0.020
Why?
Cell Fusion
1
1988
49
0.020
Why?
Emotions
1
2014
578
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2008
85
0.020
Why?
Protein C
1
2008
53
0.020
Why?
Water Microbiology
2
1999
92
0.020
Why?
Antithrombins
1
2008
70
0.020
Why?
Mice, Inbred C57BL
1
2019
6007
0.020
Why?
Genetic Markers
1
1988
332
0.020
Why?
Fibrinogen
1
2008
179
0.020
Why?
Renin-Angiotensin System
1
2007
78
0.020
Why?
Transplantation, Homologous
1
2008
415
0.020
Why?
Biopsy, Needle
1
2007
183
0.020
Why?
Rare Diseases
1
2007
114
0.020
Why?
Blood Pressure Determination
1
2007
144
0.020
Why?
Nephrectomy
1
2007
158
0.020
Why?
Biomarkers
1
2017
4284
0.010
Why?
RNA, Messenger
1
2011
2833
0.010
Why?
Immunohistochemistry
1
2007
1718
0.010
Why?
Cell Line
1
1988
2882
0.010
Why?
Anemia, Hypochromic
1
2001
2
0.010
Why?
Blood Platelet Disorders
1
2001
10
0.010
Why?
von Willebrand Diseases
1
2001
28
0.010
Why?
Estriol
1
1979
6
0.010
Why?
Estrone
1
1979
40
0.010
Why?
Menstruation
1
1979
42
0.010
Why?
Prolactin
1
1979
89
0.010
Why?
Thrombocytopenia
1
2001
205
0.010
Why?
Bolivia
1
1999
61
0.010
Why?
Luteinizing Hormone
1
1979
190
0.010
Why?
Follicle Stimulating Hormone
1
1979
249
0.010
Why?
Restaurants
1
1998
22
0.010
Why?
Swimming
1
1998
50
0.010
Why?
Food Handling
1
1998
63
0.010
Why?
Progesterone
1
1979
256
0.010
Why?
Disease Transmission, Infectious
1
1998
69
0.010
Why?
Water Supply
1
1998
89
0.010
Why?
Meat
1
1998
93
0.010
Why?
Kyphosis
1
1996
37
0.010
Why?
Halothane
1
1996
8
0.010
Why?
Analysis of Variance
1
1999
1311
0.010
Why?
Estradiol
1
1979
533
0.010
Why?
Congenital Abnormalities
1
1996
104
0.010
Why?
Population Surveillance
1
1999
485
0.010
Why?
Feces
1
1998
514
0.010
Why?
Diagnostic Imaging
1
1996
342
0.010
Why?
Ovarian Neoplasms
1
1978
592
0.010
Why?
Pedigree
3
1978
514
0.010
Why?
Nebraska
2
1976
21
0.000
Why?
Aged, 80 and over
1
1999
8295
0.000
Why?
New York
2
1976
127
0.000
Why?
Genes
1
1978
226
0.000
Why?
Genetic Linkage
1
1978
273
0.000
Why?
Oncogenic Viruses
1
1976
3
0.000
Why?
Apocrine Glands
1
1976
4
0.000
Why?
Genetic Techniques
1
1976
67
0.000
Why?
Pheochromocytoma
1
1976
67
0.000
Why?
Statistics as Topic
1
1976
284
0.000
Why?
Syndrome
1
1976
380
0.000
Why?
Klinefelter Syndrome
1
1976
69
0.000
Why?
HLA Antigens
1
1976
232
0.000
Why?
Abnormalities, Multiple
1
1976
197
0.000
Why?
Skin Diseases
1
1976
149
0.000
Why?
Pregnancy
2
1978
7208
0.000
Why?
Sarcoma
1
1976
205
0.000
Why?
Sex Factors
1
1978
2115
0.000
Why?
Thyroid Neoplasms
1
1976
349
0.000
Why?
Neoplasms
2
1976
2887
0.000
Why?
Melanoma
1
1976
761
0.000
Why?
Phenotype
1
1976
3172
0.000
Why?
Registries
1
1976
2398
0.000
Why?
Brain Neoplasms
1
1976
1327
0.000
Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)